Evaluation of the efficacy of antipsychotic attenuation of phencyclidine-disrupted prepulse inhibition in rats

Journal of Neural Transmission

Volumn 109, Issue 4, 2002, Pages 523-535

  Wiley, J L ^a   Kennedy, K L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Antipsychotics; Clozapine; Olanzapine; Phencyclidine; Schizophrenia; Spermine

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; LOXAPINE SUCCINATE; NEUROLEPTIC AGENT; OLANZAPINE; PHENCYCLIDINE; PIMOZIDE; SPERMINE; THIORIDAZINE; TIOTIXENE;

ANIMAL EXPERIMENT; ARTICLE; AUDITORY STIMULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRUG SCREENING; MALE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; STARTLE REFLEX;

ANIMALS; ANTIPSYCHOTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; EXCITATORY AMINO ACID ANTAGONISTS; MALE; NEURAL INHIBITION; PHENCYCLIDINE; RATS; RATS, SPRAGUE-DAWLEY; STARTLE REACTION;

EID: 0036209099     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020200043     Document Type: Article

References (46)

1. Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence
2. Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine
3. Phencyclidine-induced deficits in prepulse inhibition of startle are blocked by prazosin, an alpha-1 noradrenergic antagonist
4. Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response
5. Evaluation of the reinforcing effects of eliprodil in rhesus monkeys and its discriminative stimulus effects in rats
6. Evaluation of antagonists of the discriminative stimulus and response rate effects of phencyclidine
7. Pharmacology of antipsychotic drugs
8. Prestimulus effects on human startle reflex in normals and schizophrenics
9. Discriminative stimulus properties of PCP mimetics
10. Combinations of clozapine and phencyclidine: Effects on drug discrimination and behavioral inhibition in rats
11. Clozapine but not haloperidol antagonizes an MK-801 discriminative stimulus cue
12. Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors
13. Potentiation of prepulse inhibition of the startle reflex in rats: Pharmacological evaluation of the procedure as a model for detecting antipsychotic activity
14. Prepulse inhibition of the startle reflex in rats: Effects of compounds acting at various sites on the NMDA receptor complex
15. Animal models with construct validity for schizophrenia
16. A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia
17. Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats
18. The effects of haloperidol and clozapine on the disruption of sensorimotor gating induced by the noncompetitive glutamate antagonist MK-801
19. Reflex modification in the domain of startle. I. Some empirical findings and their implications for how the nervous system processes sensory input
20. Amelioration of negative symptoms in schizophrenia by glycine
21. The atypical antipsychotic, remoxipride, blocks phencyclidine-induced disruption of prepulse inhibition in the rat
22. Prepulse inhibition of acoustic startle, a measure of sensorimotor gating: Effects of antipsychotics and other agents in rats
23. Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of acoustic startle
24. 2 receptors
25. Effects of NMDA receptor ligands on sensorimotor gating in the rat
26. Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat
27. Parametric determinants in pre-stimulus modification of acoustic startle: Interaction with ketamine
28. Dopaminergic stimulation disrupts sensorimotor gating in the rat
29. Phencyclidine-like discriminative stimulus effects of polyamine modulators of N-methyl-D-aspartate receptor activity in rats
30. A systematic study of the pharmacological activities of dopamine antagonists
31. Glycine in the treatment of schizophrenia: Theory and preliminary results
32. Risperidone compared with new and reference antipsychotic drugs: In vitro and in vivo receptor binding
33. A neurochemical basis for the antipsychotic activity of loxapine: Interactions with D1, D2, D4 and serotonin 5-HT2 receptor subtypes
34. Does MK-801 discrimination constitute an animal model of schizophrenia useful for detecting atypical antipsychotics?
35. Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia
36. Seroquel restores sensorimotor gating in phencyclidine-treated rats
37. Seroquel, clozapine and chlorpromazine restore sensorimotor gating in ketamine-treated rats
38. Towards a cross-species pharmacology of sensorimotor gating: Effects of amantadine, bromocriptine, pergolide and ropinirole on prepulse inhibition of acoustic startle in rats
39. Discrepant findings of clozapine effects on prepulse inhibition of startle: Is it the route or the rat?
40. MK-801-induced stereotypy and its antagonism by neuroleptic drugs
41. Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs
42. Effective neuroleptic medication removes prepulse inhibition deficits in schizophrenic patients
43. Clozapine's effects on phencyclidine-induced disruption of prepulse inhibition of the acoustic startle response
44. Effect of repeated haloperidol administration on phencyclidine discrimination in rats
45. Nitric oxide synthase inhibitors attenuate phencyclidine-induced disruption of prepulse inhibition
46. Involvement of serotonin 2A receptors in phencyclidine-induced disruption of prepulse inhibition of the acoustic startle in rats